Publications

[behaviors and risk factors in a population of patients with sexually transmitted diseases (stds)].	300 men and women attending a municipal sexually transmitted disease clinic in guatemala city voluntarily participated in an anonymous and confidential study to determine hiv seroprevalence among patients with sexually transmitted diseases and to identify risk practices. two cases were confirmed, for a seropositivity rate of 0.7%. subjects were aged 6-62 years, with 45% between ages 21 and 30. 80% were male. 42% were married or in union. 26% of those in union reported occasional relations w ...	1992	12290618
pharmaceutical approval update.	blinatumomab (blincyto) for acute lymphoblastic leukemia; human papillomavirus 9-valent vaccine, recombinant (gardasil 9) for extended protection against cervical cancer; and hydrocodone bitartrate extended release (hysingla er) for 24-hour management of severe pain.	2015	25673958
gardasil 9 (human papillomavirus 9-valent vaccine, recombinant).		2016	27072727